Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2010

View Archived Issues

Austrian scientists claim new antidiabetic agents

CalciMedica claims new calcium release-activated calcium channel protein inhibitors

NeuroSearch identifies new monoamine reuptake inhibitors

Piramal Life Sciences presents new diacylglycerol O-acyltransferase 1 inhibitors

Novel VEGFR-2 inhibitors presented by Hutchison MediPharma

Baxter reports on Vero cell-derived influenza vaccines

Booster dose of Japanese encephalitis vaccine Ixiaro enhances immunogenicity

Pentamycin effective against bacterial vaginosis

Persistent antibody response noted in adolescents 2 years after vaccination with Men ACWY

Valnoctamide demonstrates antimanic efficacy in double-blind trial

NAVIGATOR data on cardiovascular events and diabetes in at-risk patients presented

NCI-sponsored phase I/II trial of Spectrum's belinostat initiated in thymic malignancies

CytoDyn increases funds to accelerate Cytolin trial in HIV

FDA advisory committee: insufficient trial data on pixantrone in relapsed/refractory NHL

EMA's CHMP recommends new Kepivance label in Europe

FDA and EMA respond to GSK's report on rotavirus DNA in Rotarix vaccine

BioSante reports FDA orphan drug designation and phase II data for GVAX(R) leukemia vaccine

Novel selective M1 allosteric receptor modulators disclosed at ACS meeting

Clinical Data submits vilazodone NDA for major depressive disorder to FDA

EMA completes validation of InterMune's pirfenidone MAA for IPF

FDA approves Boehringer Ingelheim's once-daily Mirapex ER for Parkinson's disease

Garnet begins dosing in phase II trial of GBT-009 for improved scar appearance

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

Pain Therapeutics reports phase I clinical data on PTI-188 in skin cancer

Innate Immune and Cephalon Australia to collaborate to develop antibodies for asthma and SLE

Teva Pharmaceutical terminates license agreement with Antisense Therapeutics for ATL-1102

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...